CRISPR Therapeutics Switches CEOs As It Approaches First … – Xconomy
Xconomy |
CRISPR Therapeutics Switches CEOs As It Approaches First …
Xconomy With its first clinical trial possibly just months away, one of the leading biotech firms using CRISPR-Cas9 gene editing technology to make drugs is turnin. Sam Kulkarni takes the helm at CRISPR Therapeutics as founding … CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer Trading Update: Crispr Therapeutics Ag (CRSP) Currently Above Chikou Line |
